×
概览
This workshop will be conducted in Japanese Language only.
Click Here to View the Program in Japanese
Online Registration has been closed. Onsite Registration will be available at Nihonbashi Life Science HUB.
项目委员会
-
Shinzo Hiroi, PhD, MPH, RPh, PMP Senior Director, Project Management, IDC ICO Real World Solutions
ICON Clinical Research GK, Japan -
Kentaro Kogushi, PhD Head of Clinical Development Neurology-Psychiatry, Japan Development
AbbVie GK, Japan -
Yusuke Nakamura, MBA, MPH Pharmaceuticals Division, Market Acccess
Bayer Yakuhin, Ltd., Japan -
Shinya Ohno, PhD, MPH Director, HTA Strategy Professional
Chugai Pharmaceutical Co., Ltd, Japan -
Masayo Sato
Eli Lilly Japan K.K., Japan -
Akihito Uda, MPH Health Economics & Outcome Reserch, Value & Access Division
Novartis Pharma K.K., Japan -
Hisashi Urushihara, DrPH Professor, Faculty of Pharmacy, Department of Pharmacy
Keio University, Japan -
Manami Yoshida, DVM Associate Director, Medical Affairs – HIV & COVID-19
Gilead Sciences K.K., Japan -
Hiroyuki Sakamaki, DrSc, PhD, MBA Professor, School of Health Innovation
Kanagawa University of Human Services, Japan -
Kuniko Shoji Vice-Dean, School of Health Innovation
Kanagawa University of Human Services, Japan
